Home › Compare › TLCO vs MRK

TLCO vs MRK: Dividend Comparison 2026

TLCO yields 222222.22% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TLCO wins by $1.4076447531278624e+30M in total portfolio value
10 years
TLCO
TLCO
● Live price
222222.22%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4076447531278624e+30M
Annual income
$1,406,399,782,569,334,400,000,000,000,000,000,000.00
Full TLCO calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — TLCO vs MRK

📍 TLCO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTLCOMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TLCO + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
TLCO pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TLCO
Annual income on $10K today (after 15% tax)
$18,888,888.89/yr
After 10yr DRIP, annual income (after tax)
$1,195,439,815,183,934,200,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, TLCO beats the other by $1,195,439,815,183,934,200,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TLCO + MRK for your $10,000?

TLCO: 50%MRK: 50%
100% MRK50/50100% TLCO
Portfolio after 10yr
$7.038223765639312e+29M
Annual income
$703,199,891,284,667,200,000,000,000,000,000,000.00/yr
Blended yield
99.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TLCO
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TLCO buys
0
MRK buys
0
No recent congressional trades found for TLCO or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTLCOMRK
Forward yield222222.22% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$1.4076447531278624e+30M$56.8K ✓
Annual income after 10y$1,406,399,782,569,334,400,000,000,000,000,000,000.00 ✓$9,798.13
Total dividends collected$1.4075632434891558e+30M$28.9K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TLCO vs MRK ($10,000, DRIP)

YearTLCO PortfolioTLCO Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$22,232,922$22,222,222.22$11,206$366.19+$22.22M → TLCO
2$46,198,082,523$46,174,293,296.41$12,650$502.35+$46198.07M → TLCO
3$89,718,752,943,223$89,669,320,994,923.30$14,407$694.19+$89718752.93M → TLCO
4$162,845,393,609,755,680$162,749,394,544,106,430.00$16,585$967.82+$162845393609.74M → TLCO
5$276,249,735,879,778,500,000$276,075,491,308,616,120,000.00$19,342$1,363.89+$276249735879778.47M → TLCO
6$437,989,462,258,048,500,000,000$437,693,875,040,657,100,000,000.00$22,913$1,947.19+$437989462258048512.00M → TLCO
7$649,026,142,700,674,900,000,000,000$648,557,493,976,058,700,000,000,000.00$27,662$2,823.89+$649026142700674875392.00M → TLCO
8$898,874,153,179,794,200,000,000,000,000$898,179,695,207,104,400,000,000,000,000.00$34,159$4,173.35+$8.988741531797941e+23M → TLCO
9$1,163,523,886,474,633,300,000,000,000,000,000$1,162,562,091,130,731,000,000,000,000,000,000.00$43,337$6,308.80+$1.1635238864746333e+27M → TLCO
10$1,407,644,753,127,862,300,000,000,000,000,000,000$1,406,399,782,569,334,400,000,000,000,000,000,000.00$56,776$9,798.13+$1.4076447531278624e+30M → TLCO

TLCO vs MRK: Complete Analysis 2026

TLCO — Stock

Teleconnect Inc. manufactures, sells, and leases age validation equipment for supermarkets and liquor stores in the Netherlands. The company's Ageviewer's system checks age of the customer remotely to prevent the sale of tobacco and alcohol to minors. It also sells and maintains vending solutions for the sale of traveling accessories and other related products at train stations and airports; performs market surveys; and broadcasts in-store commercial messages by using the age validation equipment between age checks. The company was incorporated in 1998 and is based in Breda, the Netherlands.

Full TLCO Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TLCO vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TLCO vs SCHDTLCO vs JEPITLCO vs OTLCO vs KOTLCO vs MAINTLCO vs JNJTLCO vs ABBVTLCO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.